BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

128 related articles for article (PubMed ID: 11782017)

  • 1. Contrasting roles of IL-12p40 and IL-12p35 in the development of hapten-induced colitis.
    Camoglio L; Juffermans NP; Peppelenbosch M; te Velde AA; ten Kate FJ; van Deventer SJ; Kopf M
    Eur J Immunol; 2002 Jan; 32(1):261-9. PubMed ID: 11782017
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An interleukin 12 p40-IgG2b fusion protein abrogates T cell mediated inflammation: anti-inflammatory activity in Crohn's disease and experimental colitis in vivo.
    Stallmach A; Marth T; Weiss B; Wittig BM; Hombach A; Schmidt C; Neurath M; Zeitz M; Zeuzem S; Abken H
    Gut; 2004 Mar; 53(3):339-45. PubMed ID: 14960512
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mycophenolate Mofetil Modulates Differentiation of Th1/Th2 and the Secretion of Cytokines in an Active Crohn's Disease Mouse Model.
    Lv QK; Liu JX; Li SN; Gao YJ; Lv Y; Xu ZP; Huang BX; Xu SY; Yang DX; Zeng YL; Liu DF; Wang W
    Int J Mol Sci; 2015 Nov; 16(11):26654-66. PubMed ID: 26561804
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Recombinant herpes simplex virus type 1 (HSV-1) codelivering interleukin-12p35 as a molecular adjuvant enhances the protective immune response against ocular HSV-1 challenge.
    Osorio Y; Ghiasi H
    J Virol; 2005 Mar; 79(6):3297-308. PubMed ID: 15731224
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hapten-induced colitis is associated with colonic patch hypertrophy and T helper cell 2-type responses.
    Dohi T; Fujihashi K; Rennert PD; Iwatani K; Kiyono H; McGhee JR
    J Exp Med; 1999 Apr; 189(8):1169-80. PubMed ID: 10209035
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antibodies to interleukin 12 abrogate established experimental colitis in mice.
    Neurath MF; Fuss I; Kelsall BL; Stüber E; Strober W
    J Exp Med; 1995 Nov; 182(5):1281-90. PubMed ID: 7595199
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Both IL-12p70 and IL-23 are synthesized during active Crohn's disease and are down-regulated by treatment with anti-IL-12 p40 monoclonal antibody.
    Fuss IJ; Becker C; Yang Z; Groden C; Hornung RL; Heller F; Neurath MF; Strober W; Mannon PJ
    Inflamm Bowel Dis; 2006 Jan; 12(1):9-15. PubMed ID: 16374252
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Evidence for the critical role of interleukin-12 but not interferon-gamma in the pathogenesis of experimental colitis in mice.
    Tozawa K; Hanai H; Sugimoto K; Baba S; Sugimura H; Aoshi T; Uchijima M; Nagata T; Koide Y
    J Gastroenterol Hepatol; 2003 May; 18(5):578-87. PubMed ID: 12702051
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A profibrotic function of IL-12p40 in experimental pulmonary fibrosis.
    Huaux F; Arras M; Tomasi D; Barbarin V; Delos M; Coutelier JP; Vink A; Phan SH; Renauld JC; Lison D
    J Immunol; 2002 Sep; 169(5):2653-61. PubMed ID: 12193738
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel p40-independent function of IL-12p35 is required for progression and maintenance of herpes stromal keratitis.
    Frank GM; Divito SJ; Maker DM; Xu M; Hendricks RL
    Invest Ophthalmol Vis Sci; 2010 Jul; 51(7):3591-8. PubMed ID: 20207959
    [TBL] [Abstract][Full Text] [Related]  

  • 11. IL-12p40-independent induction of protective immunity upon multiple Plasmodium berghei irradiated sporozoite immunizations.
    Romero JF; Ibrahim GH; Renggli J; Himmelrich H; Graber P; Corradin G
    Parasite Immunol; 2007 Nov; 29(11):541-8. PubMed ID: 17944743
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Hapten-induced colitis associated with maintained Th1 and inflammatory responses in IFN-gamma receptor-deficient mice.
    Camoglio L; te Velde AA; de Boer A; ten Kate FJ; Kopf M; van Deventer SJ
    Eur J Immunol; 2000 May; 30(5):1486-95. PubMed ID: 10820397
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hydrogen peroxide increases interleukin-12 p40/p70 molecular ratio and induces Th2-predominant responses in mice.
    Obata F; Hoshino A; Toyama A
    Scand J Immunol; 2006 Feb; 63(2):125-30. PubMed ID: 16476011
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cholera toxin subunit B inhibits IL-12 and IFN-{gamma} production and signaling in experimental colitis and Crohn's disease.
    Coccia EM; Remoli ME; Di Giacinto C; Del Zotto B; Giacomini E; Monteleone G; Boirivant M
    Gut; 2005 Nov; 54(11):1558-64. PubMed ID: 16105891
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Interleukin-12 is essential for a protective Th1 response in mice infected with Cryptococcus neoformans.
    Decken K; Köhler G; Palmer-Lehmann K; Wunderlin A; Mattner F; Magram J; Gately MK; Alber G
    Infect Immun; 1998 Oct; 66(10):4994-5000. PubMed ID: 9746609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Toll-like receptor 2 controls the gamma interferon response to Francisella tularensis by mouse liver lymphocytes.
    Hong KJ; Wickstrum JR; Yeh HW; Parmely MJ
    Infect Immun; 2007 Nov; 75(11):5338-45. PubMed ID: 17785474
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Hapten-induced model of murine inflammatory bowel disease: mucosa immune responses and protection by tolerance.
    Elson CO; Beagley KW; Sharmanov AT; Fujihashi K; Kiyono H; Tennyson GS; Cong Y; Black CA; Ridwan BW; McGhee JR
    J Immunol; 1996 Sep; 157(5):2174-85. PubMed ID: 8757344
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Proteinase-activated receptor 2 is an anti-inflammatory signal for colonic lamina propria lymphocytes in a mouse model of colitis.
    Fiorucci S; Mencarelli A; Palazzetti B; Distrutti E; Vergnolle N; Hollenberg MD; Wallace JL; Morelli A; Cirino G
    Proc Natl Acad Sci U S A; 2001 Nov; 98(24):13936-41. PubMed ID: 11717450
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alloantigen-reactive Th1 development in IL-12-deficient mice.
    Piccotti JR; Li K; Chan SY; Ferrante J; Magram J; Eichwald EJ; Bishop DK
    J Immunol; 1998 Feb; 160(3):1132-8. PubMed ID: 9570526
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Interleukin 19 reduces inflammation in chemically induced experimental colitis.
    Matsuo Y; Azuma YT; Kuwamura M; Kuramoto N; Nishiyama K; Yoshida N; Ikeda Y; Fujimoto Y; Nakajima H; Takeuchi T
    Int Immunopharmacol; 2015 Dec; 29(2):468-475. PubMed ID: 26476684
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.